Evidence map›Paper›PMID 33640067›Full record

Trial reportLancet (London, England)2021

Impact and cost-effectiveness of a lethal house lure against malaria transmission in central Côte d'Ivoire: a two-arm, cluster-randomised controlled trial.

Eleanore D Sternberg, Jackie Cook, Ludovic P Ahoua Alou, Serge Brice Assi, Alphonsine A Koffi, Dimi T Doudou, Carine J Aoura, Rosine Z Wolie, Welbeck A Oumbouke, Eve Worrall and 3 more

Registry-linked trialOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Lancet (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05736679 (EaveTubes for Control of Vector Borne Diseases in Côte d'Ivoire), which is not on this map. Cited by 33 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 3 pooled it
11.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05736679 naactive not recruitingnot on this mapstarted 2023, after this paper: background citation

EaveTubes for Control of Vector Borne Diseases in Côte d'Ivoire

TypeinterventionalSponsorUniversity of Notre DameRan2023 to 2025Enrolled1,870ConditionsMalariaArmsIn2Care EaveTube
3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 3 syntheses or guidelines pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. House modifications for preventing malaria.The Cochrane database of systematic reviews · 2022
    Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 4 countries.

Eleanore D SternbergDepartment of Entomology, Center for Infectious Disease Dynamics, The Pennsylvania State University, University Park, PA, USA; Department of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom. Electronic address: eleanore.sternberg@lstmed.ac.uk.
Jackie CookDepartment of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Ludovic P Ahoua AlouInstitut Pierre Richet, Institut National de Santé Publique, Bouaké, Côte d'Ivoire.
Serge Brice AssiInstitut Pierre Richet, Institut National de Santé Publique, Bouaké, Côte d'Ivoire.
Alphonsine A KoffiInstitut Pierre Richet, Institut National de Santé Publique, Bouaké, Côte d'Ivoire.
Dimi T DoudouLaboratoire de Santé, Nutrition et Hygiène, Centre de Recherche pour le Développement, Université Alassane Ouattara, Bouaké, Côte d'Ivoire.
Carine J AouraInstitut Pierre Richet, Institut National de Santé Publique, Bouaké, Côte d'Ivoire.
Rosine Z WolieInstitut Pierre Richet, Institut National de Santé Publique, Bouaké, Côte d'Ivoire; Laboratoire de genetique, Unité de Formation et de Recherche en Biosciences, Université Felix Houphouët Boigny, Abidjan, Côte d'Ivoire.
Welbeck A OumboukeInnovative Vector Control Consortium, Liverpool School of Tropical Medicine, Liverpool, United Kingdom; Department of Disease Control, London School of Hygiene & Tropical Medicine, London, UK; Institut Pierre Richet, Institut National de Santé Publique, Bouaké, Côte d'Ivoire.
Eve WorrallDepartment of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Immo KleinschmidtDepartment of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; Wits Research Institute for Malaria, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa; Southern African Development Community Malaria Elimination Eight Secretariat, Windhoek, Namibia.
Raphael N'GuessanDepartment of Disease Control, London School of Hygiene & Tropical Medicine, London, UK; Institut Pierre Richet, Institut National de Santé Publique, Bouaké, Côte d'Ivoire.
Matthew B ThomasDepartment of Entomology, Center for Infectious Disease Dynamics, The Pennsylvania State University, University Park, PA, USA; York Environmental Sustainability Institute and Department of Biology, University of York, York, UK.
Institut National de Santé Publique · CILiverpool School of Tropical Medicine · GBLondon School of Hygiene & Tropical Medicine · GBPennsylvania State University · USUniversité Alassane Ouattara · CIUniversity of the Witwatersrand · ZAUniversity of York · GB

Funding

Medical Research Council MR/R010161/1
6 · The paper itself

Abstract

backgroundNew vector control tools are required to sustain the fight against malaria. Lethal house lures, which target mosquitoes as they attempt to enter houses to blood feed, are one approach. Here we evaluated lethal house lures consisting of In2Care (Wageningen, Netherlands) Eave Tubes, which provide point-source insecticide treatments against host-seeking mosquitoes, in combination with house screening, which aims to reduce mosquito entry.

methodsWe did a two-arm, cluster-randomised controlled trial with 40 village-level clusters in central Côte d'Ivoire between Sept 26, 2016, and April 10, 2019. All households received new insecticide-treated nets at universal coverage (one bednet per two people). Suitable households within the clusters assigned to the treatment group were offered screening plus Eave Tubes, with Eave Tubes treated using a 10% wettable powder formulation of the pyrethroid β-cyfluthrin. Because of the nature of the intervention, treatment could not be masked for households and field teams, but all analyses were blinded. The primary endpoint was clinical malaria incidence recorded by active case detection over 2 years in cohorts of children aged 6 months to 10 years. This trial is registered with ISRCTN, ISRCTN18145556.

findings3022 houses received screening plus Eave Tubes, with an average coverage of 70% across the intervention clusters. 1300 eligible children were recruited for active case detection in the control group and 1260 in the intervention group. During the 2-year follow-up period, malaria case incidence was 2·29 per child-year (95% CI 1·97-2·61) in the control group and 1·43 per child-year (1·21-1·65) in the intervention group (hazard ratio 0·62, 95% CI 0·51-0·76; p<0·0001). Cost-effectiveness simulations suggested that screening plus Eave Tubes has a 74·0% chance of representing a cost-effective intervention, compared with existing healthcare activities in Côte d'Ivoire, and is similarly cost-effective to other core vector control interventions across sub-Saharan Africa. No serious adverse events associated with the intervention were reported during follow-up.

interpretationScreening plus Eave Tubes can provide protection against malaria in addition to the effects of insecticide-treated nets, offering potential for a new, cost-effective strategy to supplement existing vector control tools. Additional trials are needed to confirm these initial results and further optimise Eave Tubes and the lethal house lure concept to facilitate adoption.

fundingThe Bill & Melinda Gates Foundation.

Indexed as

Cost-Benefit AnalysisInsecticide-Treated BednetsMalariaAnimalsChildChild, PreschoolCote d'IvoireFemaleHumansInfantMaleMosquito ControlPyrethrinsPyrethrins

Identifiers

PMID33640067
PMCPMC7910282
OpenAlexW3133887945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.